- No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
H2A
GER
Week ended 07 Aug 2026
Weekly Investor Report
H2APEX Group SCA · Basic Materials · Specialty Chemicals
Latest close
0.79 EUR
1.5%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -25.4% below the Trend Line and sits at 1.9% of its 52-week range. The latest completed week returned 1.5%, after a -7.7% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 42/100.
Setup score
12
out of 100
Latest Close
0.79 EUR
7 Aug 2026
1W Return
1.5%
latest completed week
4W Return
-7.7%
short-term follow-through
12W Return
-30.0%
quarterly tape
Trend Breadth
0.0%
0 of 52 weeks active
Volume Ratio
1.0x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
1.5%
Latest completed week; four-week move -7.7%.
Indicator stack
0/0
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 37.05%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
42/100
2 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -25.4% below the Trend Line and sits at 1.9% of its 52-week range. The latest completed week returned 1.5%, after a -7.7% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.0x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0012-week average 0.03
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure8/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.00Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -7.7% over four weeks, -30.0% over 12 weeks, and -60.0% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.55Latest activity-pressure read.
Pressure change-1143.8%Four-week change in activity pressure.
Leadership-45.13Latest relative-leadership reading.
RS change-8.5%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is neither clearly cheap nor expensive.
Factor week 09 Aug 2026
Financial statements through 31 Mar 2026
Field coverage 76%
Model confidence 71%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength2/100Blend of value, momentum, and quality. Underlying universe rank 99; rank 1 is best.
Value31/100Relative valuation strength. Underlying universe rank 70; rank 1 is best.
Quality1/100Profitability and accounting quality. Underlying universe rank 100; rank 1 is best.
Momentum2/100Medium-term price momentum. Underlying universe rank 99; rank 1 is best.
Growth11/100Revenue and earnings growth. Underlying universe rank 90; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- - Price divided by trailing earnings.
- Price / sales
- 3.5x Market value relative to trailing revenue.
- EV / EBITDA
- - Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- -64.7% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- -54.1% Gross profit retained from each unit of revenue.
- Operating margin
- -307.1% Operating profit retained from revenue.
- Free-cash-flow margin
- -420.1% Free cash flow generated from revenue.
- Return on invested capital
- -49.5% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- -66.3% Latest one-year revenue growth.
- EPS growth
- - Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- - Latest one-year free-cash-flow growth.
- Piotroski F-score
- 1/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- - Cash dividends relative to market value.
- Buyback yield
- -25.3% Net share repurchases relative to market value.
- Shareholder yield
- -25.3% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- -1.2x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment42/100
Weighted news tone is neutral across 2 relevant articles.
0 positive · 1 neutral · 1 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-71.0%Distance below the 52-week high.
13-week volatility4.9%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher10 of 2614 weeks finished lower.
Best week+16.8%Week of 17 Apr.
Worst week-13.5%Week of 13 Mar.
Latest week+1.5%Week of 7 Aug.
Shape of recent returns
Strong gains5
Modest gains5
Flat weeks2
Modest losses4
Sharp losses10
Recent vol4.9%13-week weekly-return volatility.
Base vol13.7%52-week weekly-return volatility.
Up/down split18/31Count of positive and negative weeks in the 52-week window.
Average skew9.2% / -7.1%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorDE Basic Materials
4-week rank42 / 44
Group average3.5%
Trend breadth47.7%
Trend47.7%active weekly trend signals
MD20.5%positive activity pressure
RS50.0%positive relative leadership
Four-week leaders
IndustryDE Specialty Chemicals
4-week rank17 / 18
Group average1.0%
Trend breadth61.1%
Trend61.1%active weekly trend signals
MD44.4%positive activity pressure
RS50.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape12/100
Trend, activity pressure, participation, and risk combine to a 12/100 tape read.
Indicator analysis32/100Latest 12-week confirmation: trend 0/12, activity pressure 8/12, relative leadership 0/12.
Activity pressure 0.00; No reversal markers Next-Week ExpectancyNegative 37.05%Next-week expectancy is negative with a 37.05% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors7/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 99; Small Cap Core rank 76 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment42/100Weighted news tone is neutral across 2 relevant articles.
Downgrade: Here's How Analysts See H2APEX Group SCA (ETR:H2A) Performing In The Near Term Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 0.79 EUR | 1.5% | 1.06 EUR | 3.60 EUR | -0.55 | -45.13 | 11.8K | Off |
| 31 Jul 2026 | 0.78 EUR | -3.5% | 1.09 EUR | 3.63 EUR | -0.37 | -45.50 | 10.6K | Off |
| 24 Jul 2026 | 0.80 EUR | 0.2% | 1.13 EUR | 3.67 EUR | -0.21 | -43.37 | 1.1K | Off |
| 17 Jul 2026 | 0.80 EUR | -6.1% | 1.14 EUR | 3.70 EUR | -0.05 | -43.88 | 16.4K | Off |
| 10 Jul 2026 | 0.85 EUR | 4.9% | 1.16 EUR | 3.74 EUR | 0.05 | -41.59 | 5.9K | Off |
| 3 Jul 2026 | 0.81 EUR | -3.1% | 1.17 EUR | 3.77 EUR | 0.08 | -46.63 | 2 | Off |
| 26 Jun 2026 | 0.84 EUR | -11.8% | 1.19 EUR | 3.81 EUR | 0.10 | -43.38 | 140 | Off |
| 19 Jun 2026 | 0.95 EUR | 0.0% | 1.21 EUR | 3.84 EUR | 0.13 | -37.61 | 150 | Off |
| 12 Jun 2026 | 0.95 EUR | -1.9% | 1.22 EUR | 3.88 EUR | 0.14 | -37.62 | 113 | Off |
| 5 Jun 2026 | 0.97 EUR | 0.2% | 1.24 EUR | 3.91 EUR | 0.16 | -37.60 | 4.6K | Off |
| 29 May 2026 | 0.97 EUR | -7.8% | 1.27 EUR | 3.94 EUR | 0.10 | -39.40 | 27.7K | Off |
| 22 May 2026 | 1.05 EUR | -6.7% | 1.29 EUR | 3.97 EUR | 0.14 | -34.71 | 46.4K | Off |
| 15 May 2026 | 1.12 EUR | 6.1% | 1.31 EUR | 4.01 EUR | -0.14 | -28.45 | 24.4K | Off |
| 8 May 2026 | 1.06 EUR | -5.4% | 1.33 EUR | 4.05 EUR | -0.44 | -34.72 | 27.0K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.